| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $7,650,566 | 35 | 100 |
| Bumpus Namandje | director | 0 | $0 | 2 | $28,129 | $-28,129 |
| HERSHBERG ROBERT | director | 0 | $0 | 1 | $125,000 | $-125,000 |
| Taylor Ben R | Chief Financial Officer | 0 | $0 | 3 | $157,704 | $-157,704 |
| Khan Najat | Chief R&D Commercial Officer | 0 | $0 | 4 | $806,534 | $-806,534 |
| Gibson Christopher | Chief Executive Officer | 0 | $0 | 14 | $2.19M | $-2.19M |
| Borgeson Blake | director | 0 | $0 | 11 | $4.34M | $-4.34M |
Recursion Pharmaceuticals, Inc. operates as a biotechnology firm currently in its clinical development phase. The company's mission is to revolutionize drug discovery by decoding biological processes, utilizing an integrated approach that combines technological innovations across biology, chemistry, automation, data science, and engineering. Their developmental pipeline features several clinical-stage compounds: REC-994, which is advancing through Phase IIa trials for cerebral cavernous malformation; REC-3599, currently in Phase I trials for …
Over the last 12 months, insiders at Recursion Pharmaceuticals, Inc. have bought $0 and sold $7.65M worth of Recursion Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Recursion Pharmaceuticals, Inc. have bought $28.87M and sold $15.61M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 66,822 shares for transaction amount of $522,354 was made by Mubadala Investment Co PJSC (10 percent owner) on 2023‑03‑02.
| 2026-10-06 | Sale | Borgeson Blake | director | 50,000 0.01% | $4.84 | $242,000 | -17.22% | |
| 2026-10-06 | Sale | HERSHBERG ROBERT | director | 25,000 0.0051% | $5.00 | $125,000 | -17.22% | |
| 2026-09-08 | Sale | Khan Najat | CEO and President | 22,408 0.0043% | $3.52 | $78,822 | +11.34% | |
| 2026-09-01 | Sale | Borgeson Blake | director | 30,000 0.0057% | $3.34 | $100,200 | +13.21% | |
| 2026-08-04 | Sale | Borgeson Blake | director | 30,000 0.0056% | $3.25 | $97,500 | +8.61% | |
| 2026-07-07 | Sale | Borgeson Blake | director | 40,000 0.0092% | $3.96 | $158,500 | -10.09% | |
| 2026-06-18 | Sale | Bumpus Namandje | director | 3,963 0.0009% | $3.18 | $12,602 | +8.05% | |
| 2026-06-05 | Sale | Khan Najat | CEO and President | 23,588 0.005% | $3.58 | $84,459 | +3.16% | |
| 2026-06-05 | Sale | Gibson Christopher | director | 40,000 0.0085% | $3.62 | $144,800 | +3.16% | |
| 2026-06-03 | Sale | Bumpus Namandje | director | 4,386 0.001% | $3.54 | $15,526 | -1.30% | |
| 2026-06-02 | Sale | Borgeson Blake | director | 30,000 0.0068% | $3.68 | $110,400 | -4.71% | |
| 2026-05-22 | Sale | Gibson Christopher | director | 40,000 0.0092% | $3.08 | $123,200 | +14.29% | |
| 2026-05-07 | Sale | Gibson Christopher | director | 40,000 0.0092% | $3.37 | $134,800 | +2.29% | |
| 2026-05-05 | Sale | Borgeson Blake | director | 30,000 0.007% | $3.52 | $105,600 | -0.74% | |
| 2026-04-22 | Sale | Gibson Christopher | director | 40,000 0.0087% | $3.61 | $144,400 | -9.12% | |
| 2026-04-07 | Sale | Borgeson Blake | director | 30,000 0.0065% | $3.10 | $93,000 | +6.90% | |
| 2026-04-07 | Sale | Gibson Christopher | director | 40,000 0.0087% | $3.10 | $124,000 | +6.90% | |
| 2026-03-23 | Sale | Gibson Christopher | director | 40,000 0.009% | $3.25 | $130,000 | +4.49% | |
| 2026-03-17 | Sale | Taylor Ben R | Chief Financial Officer | 7,956 0.0018% | $3.39 | $26,971 | -1.75% | |
| 2026-03-09 | Sale | Khan Najat | CEO and President | 28,298 0.0061% | $3.35 | $94,660 | -3.85% |
| Mubadala Investment Co PJSC | 10 percent owner | 12985927 2.1756% | $47.79M | 42 | 0 | <0.0001% |
| Lux Ventures IV, L.P. | 10 percent owner | 100000 0.0168% | $368,000.00 | 1 | 0 | <0.0001% |
$21,345,882 | 83 | 94.45% | $2.19B | |
$47,419,530 | 58 | 17.20% | $1.96B | |
$1,376,668 | 53 | 18.46% | $2.1B | |
$108,353,116 | 49 | 15.41% | $2.17B | |
$586,486,795 | 47 | 4.28% | $2.38B |
| Increased Positions | 193 | +56.6% | 52M | +16.4% |
| Decreased Positions | 141 | -41.35% | 35M | -10.82% |
| New Positions | 65 | New | 5M | New |
| Sold Out Positions | 54 | Sold Out | 25M | Sold Out |
| Total Postitions | 393 | +15.25% | 337M | +5.59% |
| Vanguard Group Inc | $167,077.00 | 7.74% | 39.78M | +4M | +10.28% | 2025-09-30 |
| Ark Investment Management Llc | $140,891.00 | 6.53% | 33.55M | +556,868 | +1.69% | 2025-09-30 |
| Blackrock, Inc. | $133,307.00 | 6.18% | 31.74M | +3M | +11.87% | 2025-09-30 |
| Baillie Gifford & Co | $100,711.00 | 4.67% | 23.98M | -195,120 | -0.81% | 2025-09-30 |
| State Street Corp | $76,729.00 | 3.55% | 18.27M | +7M | +63.41% | 2025-09-30 |
| Softbank Group Corp. | $61,603.00 | 2.85% | 14.67M | 0 | 0% | 2025-09-30 |
| Kinnevik Ab (Publ) | $56,424.00 | 2.61% | 13.43M | 0 | 0% | 2025-09-30 |
| Mubadala Investment Co Pjsc | $54,541.00 | 2.53% | 12.99M | 0 | 0% | 2025-09-30 |
| Mic Capital Management Uk Llp | $40,505.00 | 1.88% | 9.64M | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $40,419.00 | 1.87% | 9.62M | +2M | +23.75% | 2025-09-30 |